Afleveringen
-
Despite taking the same medication for 23 years, Emily Schaller shares the prior authorization battle she and other cystic fibrosis patients fight each January. The Detroit native also explains how the lifestyle she’s adopted has improved her health, and how her insurer's cost-cutting tactics needlessly delay medications, derailing her efforts.
-
Eileen Attar’s son Brady lives with epidermolysis bullosa, battling constant sores all over his body. When Eileen’s not caring for Brady and treating his wounds, she’s busy fighting her health insurance company to cover the bandages necessary to keep him alive.
-
Zijn er afleveringen die ontbreken?
-
In this episode, Frank Lavernia, MD, explains how insulin pricing has evolved, why it’s becoming unaffordable and what that means for diabetes patients. He also describes a new trend in pharmacies’ distribution of insulin pens.
-
Challenges for cystic fibrosis patients don’t stop with managing their disease. Cystic Fibrosis Research Incorporated’s executive director Siri Vaeth describes providing input to the Institute for Clinical and Economic Review about the value of new cystic fibrosis treatments.
-
Health plans are questioning doctors' prescriptions, delaying access to medicine and distracting staff from patient care. Adam Friedman, MD, of the Derma Care Access Network explains why enough is enough.
-
Gout is more painful, prevalent and expensive than you thought. Researcher Kenneth Thorpe, PhD, of the Partnership to Fight Chronic Disease uses Gout Awareness Day to set the record straight.
